Roman Kasianov - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Roman Kasianov's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Roman Kasianov

Roman Kasianov

Verified

Director and Head of Content, BiopharmaTrend

Kyiv City

Final Covers

health & well being., SAP Related Discussions, Scientific Research, Technology And Innovation , Personal Development , Motivation

Doesn’t Cover

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 210

  • Elix and PRISM BioLab Partner to Tackle Hard-to-Drug Protein Targets with AI

    By Roman Kasianov

    Apr. 16, 2025

  • Weekly Tech+Bio Highlights #36: Defining Modern AI Drug Discovery

    By Roman Kasianov

    Apr. 15, 2025

  • Elix and PRISM BioLab Partner to Tackle Hard-to-Drug Protein Targets with AI

    By Roman Kasianov

    Apr. 16, 2025

As seen in

Company Info

BiopharmaTrend

BioPharmaTrend.com is a London-based digital platform established in 2016. It focuses on providing news, trends, and analysis for the biotechnology, pharmaceutical, and healthcare sectors. The platform serves professionals looking for insights into technological advancements, investment trends, and industry events. The company offers a range of services, including industry insights through market research and technology scouting, as well as content streams featuring articles, interviews, and case studies. It also provides educational resources that simplify complex topics for decision-makers in the life sciences field. Additionally, BioPharmaTrend.com collaborates with an advisory board to ensure the relevance and accuracy of its content. Targeting investors, business leaders, consultants, and government professionals, BioPharmaTrend.com aims to deliver reliable insights that support informed decision-making in the biopharma and healthcare industries.

, ,

Founded: 2016